chr8-144474287-T-C
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting
The NM_003923.3(FOXH1):c.1049A>G(p.Asp350Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000365 in 1,604,792 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. D350D) has been classified as Likely benign.
Frequency
Consequence
NM_003923.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FOXH1 | ENST00000377317.5 | c.1049A>G | p.Asp350Gly | missense_variant | Exon 3 of 3 | 1 | NM_003923.3 | ENSP00000366534.4 | ||
| KIFC2 | ENST00000645548.2 | c.*898T>C | downstream_gene_variant | NM_001369769.2 | ENSP00000494595.1 | |||||
| KIFC2 | ENST00000301332.3 | c.*837T>C | downstream_gene_variant | 1 | ENSP00000301332.2 | |||||
| KIFC2 | ENST00000643461.1 | n.*85T>C | downstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.000434 AC: 66AN: 152122Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000243 AC: 59AN: 242722 AF XY: 0.000242 show subpopulations
GnomAD4 exome AF: 0.000357 AC: 519AN: 1452552Hom.: 0 Cov.: 35 AF XY: 0.000356 AC XY: 257AN XY: 721562 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000434 AC: 66AN: 152240Hom.: 0 Cov.: 33 AF XY: 0.000363 AC XY: 27AN XY: 74432 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Holoprosencephaly sequence Uncertain:2
This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 350 of the FOXH1 protein (p.Asp350Gly). This variant is present in population databases (rs138792321, gnomAD 0.06%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with holoprosencephaly and/or tetralogy of Fallot (PMID: 18538293). ClinVar contains an entry for this variant (Variation ID: 458508). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt FOXH1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
not provided Uncertain:2
The FOXH1 c.1049A>G; p.Asp350Gly variant (rs138792321) is reported in the literature in two individuals affected with holoprosencephaly, one of whom was homozygous for the variant, and another individual with tetralogy of Fallot (Roessler 2008). This variant is found in the general population with an overall allele frequency of 0.02% (67/274084 alleles) in the Genome Aggregation Database. The aspartate at codon 350 is weakly conserved, but computational analyses (SIFT: damaging, PolyPhen-2: benign) predict conflicting effects of this variant on protein structure/function. This variant also exhibited decreased ability to rescue zebrafish morphant defects, however the extent and significance of such decreased activity is unclear. Due to limited information, the clinical significance of the p.Asp350Gly variant is uncertain at this time. References: Roessler et al., Reduced NODAL signaling strength via mutation of several pathway members including FOXH1 is linked to human heart defects and holoprosencephaly. Am J Hum Genet. 2008 Jul;83(1):18-29. -
In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 20497191, 18538293) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at